| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $17.50B | $17.28B | $14.59B |
| YoY Revenue Growth % | +1.2% | +18.5% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $1.88B | $1.62B | $2.97B |
| Operating Margin % | 10.7% | 9.4% | 20.4% |
| Net Income (GAAP) | $1.59B | $1.37B | $2.52B |
| EBITDA (Normalized) | $2.51B | $2.24B | $3.50B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $3.07B | $4.96B | $4.55B |
| Capital Expenditures (CapEx) | $787.3M | $777.6M | $656.4M |
| Free Cash Flow (FCF) | $2.28B | $4.18B | $3.90B |
| FCF Margin % | 13.0% | 24.2% | 26.7% |
| Return on Invested Capital (ROIC %) | 5.0% | 4.8% | 22.2% |
| Cash & Short-Term Equivalents | — | — | — |
| Total Debt (Short + Long Term) | $21.17B | $19.11B | $4.10B |
| Total Stockholders' Equity | $15.46B | $13.88B | $8.40B |